Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
(We use semaglutide 2.4 mg to describe the drug marketed as Wegovy independent of dose to distinguish it from other brands of semaglutide-containing products [i.e., Ozempic, Rybelsus] that have different indications and/or routes of administration.) Clinical trials in the Semaglutide Treatment Effect in People with Obesity (STEP) program have demonstrated the efficacy of semaglutide 2.4 mg in reducing weight in adults with obesity and overweight [9]
In trials, it is a triple agonist it acts on three hormone pathways (GLP-1, GIP, and glucagon), one more than tirzepatide and two more than semaglutide
The rapid weight loss observed with GLP-1RA has been implicated in facial aging
Il brevetto di Semaglutide scade in Brasile nel marzo 2026
